A phase 2 trial in colorectal cancer, run by Guangdong Provincial People's Hospital, not yet recruiting.
PCSK9 Inhibitors in Combination With Advanced Treatment Strategies for the Treatment of Advanced Colorectal Cancer With pMMR/MSS is a phase 2, randomised interventional study registered as NCT06391905 by Guangdong Provincial People's Hospital, with a registry enrolment figure of 60 participants, started 2024-05-06 and due to reach its primary completion in 2028-04-06. Interventions recorded: PCSK9 inhibitor in combination with standard advanced first-line regimen group; standard advanced first-line regimen group. Conditions listed: Colorectal Cancer. Primary outcome: Objective response rateObjective response rate (ORR). Colorectal eligibility wording from the registry: "Histologically confirmed colorectal adenocarcinoma with pMMR/MSS;". No results are recorded here; the registry entry is the source.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.
Shares Colon cancer (adenocarcinoma of the colon), Colorectal cancer trials open today (registry snapshot), Rectal cancer and the tag colorectal-deep-dive.